Investigation of novel sorafenib tosylate loaded biomaterial based nano-cochleates dispersion system for treatment of hepatocellular carcinoma

Sorafenib tosylate (ST), a European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) approved orally active anticancer drug for liver cancer therapy. However, ST shows low or...